State Street SPDR S&P Biotech ETF
793 hedge funds and large institutions have $16.4B invested in State Street SPDR S&P Biotech ETF in 2025 Q4 according to their latest regulatory filings, with 218 funds opening new positions, 227 increasing their positions, 204 reducing their positions, and 51 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
6% more funds holding in top 10
Funds holding in top 10: 18 → 19 (+1)
16.62% less ownership
Funds ownership: 214.6% → 197.98% (-17%)
51% less call options, than puts
Call options by funds: $3.1B | Put options by funds: $6.39B
Holders
793
Holding in Top 10
19
Calls
$3.1B
Puts
$6.39B
Top Buyers
| 1 | +$1.22B | |
| 2 | +$391M | |
| 3 | +$241M | |
| 4 |
Two Sigma Investments
New York
|
+$201M |
| 5 |
Citigroup
New York
|
+$188M |
Top Sellers
| 1 | -$1.18B | |
| 2 | -$325M | |
| 3 | -$161M | |
| 4 |
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Toronto,
Ontario, Canada
|
-$141M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$90.1M |
